Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrition Act is a Japanese biotechnology company specializing in the research, development, and commercialization of functional food ingredients and nutraceuticals. The company is best known for its work with Gliisodin, a patented melon-derived superoxide dismutase (SOD) complexed with gliadin for enhanced bioavailability. Nutrition Act provides high-quality raw materials and finished supplement formulations to the global healthcare and cosmetic industries. Their business model encompasses ingredient sourcing, clinical research to validate efficacy, and the distribution of health-promoting products. The company maintains a strong focus on evidence-based wellness solutions, particularly in the fields of anti-aging and metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrition Act.